Skip to content

Nurix Therapeutics, Inc. NRIX Property, plant and equipment at cost

Property, plant and equipment at cost at other companies

Nuvation Bio logo
Nuvation BioNUVB

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$2B+40.1%

Profitability

See full
Operating margin-439.3%+35.3pp
Net margin-411.4%+52.7pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s property, plant and equipment at cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s property, plant and equipment at cost?
Nurix Therapeutics, Inc. (NRIX) reported property, plant and equipment at cost of $61.42M in Q4 2025.
How has Nurix Therapeutics, Inc.'s property, plant and equipment at cost changed year-over-year?
Nurix Therapeutics, Inc.'s property, plant and equipment at cost increased by 11.2% year-over-year, from $55.21M to $61.42M.
What is the long-term trend for Nurix Therapeutics, Inc.'s property, plant and equipment at cost?
Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s property, plant and equipment at cost has grown at a 17.8% compound annual growth rate (CAGR), from $36.83M to $60.27M.